These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 36943122)
1. [Cystinosis: From the gene identification to the first gene therapy clinical trial]. Cherqui S Med Sci (Paris); 2023 Mar; 39(3):253-261. PubMed ID: 36943122 [TBL] [Abstract][Full Text] [Related]
2. Hematopoietic Stem Cell Gene Therapy for Cystinosis: From Bench-to-Bedside. Cherqui S Cells; 2021 Nov; 10(12):. PubMed ID: 34943781 [TBL] [Abstract][Full Text] [Related]
3. Deficiency of the sedoheptulose kinase (Shpk) does not alter the ability of hematopoietic stem cells to rescue cystinosis in the mouse model. Goodman S; Khan M; Sharma J; Li Z; Cano J; Castellanos C; Estrada MV; Gertsman I; Cherqui S Mol Genet Metab; 2021 Dec; 134(4):309-316. PubMed ID: 34823997 [TBL] [Abstract][Full Text] [Related]
4. Is genetic rescue of cystinosis an achievable treatment goal? Cherqui S Nephrol Dial Transplant; 2014 Mar; 29(3):522-8. PubMed ID: 23861466 [TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell gene therapy for the multisystemic lysosomal storage disorder cystinosis. Harrison F; Yeagy BA; Rocca CJ; Kohn DB; Salomon DR; Cherqui S Mol Ther; 2013 Feb; 21(2):433-44. PubMed ID: 23089735 [TBL] [Abstract][Full Text] [Related]
6. Controversies and research agenda in nephropathic cystinosis: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. Langman CB; Barshop BA; Deschênes G; Emma F; Goodyer P; Lipkin G; Midgley JP; Ottolenghi C; Servais A; Soliman NA; Thoene JG; Levtchenko EN; Kidney Int; 2016 Jun; 89(6):1192-203. PubMed ID: 27181776 [TBL] [Abstract][Full Text] [Related]
7. Cystinosin-deficient rats recapitulate the phenotype of nephropathic cystinosis. Hollywood JA; Kallingappa PK; Cheung PY; Martis RM; Sreebhavan S; 'Atiola RD; Chatterjee A; Buckels EJ; Matthews BG; Lewis PM; Davidson AJ Am J Physiol Renal Physiol; 2022 Aug; 323(2):F156-F170. PubMed ID: 35695380 [TBL] [Abstract][Full Text] [Related]
8. Effects of long-term cysteamine treatment in patients with cystinosis. Ariceta G; Giordano V; Santos F Pediatr Nephrol; 2019 Apr; 34(4):571-578. PubMed ID: 29260317 [TBL] [Abstract][Full Text] [Related]
9. Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis. Cherqui S; Sevin C; Hamard G; Kalatzis V; Sich M; Pequignot MO; Gogat K; Abitbol M; Broyer M; Gubler MC; Antignac C Mol Cell Biol; 2002 Nov; 22(21):7622-32. PubMed ID: 12370309 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic HSCT transfers wild-type cystinosin to nonhematological epithelial cells in cystinosis: First human report. Elmonem MA; Veys K; Oliveira Arcolino F; Van Dyck M; Benedetti MC; Diomedi-Camassei F; De Hertogh G; van den Heuvel LP; Renard M; Levtchenko E Am J Transplant; 2018 Nov; 18(11):2823-2828. PubMed ID: 30030899 [TBL] [Abstract][Full Text] [Related]
11. Nephropathic cystinosis: an update on genetic conditioning. Topaloglu R Pediatr Nephrol; 2021 Jun; 36(6):1347-1352. PubMed ID: 32564281 [TBL] [Abstract][Full Text] [Related]
12. CTNS mRNA molecular analysis revealed a novel mutation in a child with infantile nephropathic cystinosis: a case report. Papizh S; Serzhanova V; Filatova A; Skoblov M; Tabakov V; van den Heuvel L; Levtchenko E; Prikhodina L BMC Nephrol; 2019 Oct; 20(1):400. PubMed ID: 31672123 [TBL] [Abstract][Full Text] [Related]
13. [From gene to disease: cystinosis]. Levtchenko EN; Wilmer M; de Graaf-Hess AC; van den Heuvel LP; Blom H; Monnens LA Ned Tijdschr Geneeskd; 2004 Mar; 148(10):476-8. PubMed ID: 15042893 [TBL] [Abstract][Full Text] [Related]
14. Cystinosis (ctns) zebrafish mutant shows pronephric glomerular and tubular dysfunction. Elmonem MA; Khalil R; Khodaparast L; Khodaparast L; Arcolino FO; Morgan J; Pastore A; Tylzanowski P; Ny A; Lowe M; de Witte PA; Baelde HJ; van den Heuvel LP; Levtchenko E Sci Rep; 2017 Feb; 7():42583. PubMed ID: 28198397 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy of cystinosin supplementation through CTNS mRNA delivery in experimental models for cystinosis. Bondue T; Berlingerio SP; Siegerist F; Sendino-Garví E; Schindler M; Baelde HJ; Cairoli S; Goffredo BM; Arcolino FO; Dieker J; Janssen MJ; Endlich N; Brock R; Gijsbers R; van den Heuvel L; Levtchenko E Sci Rep; 2023 Nov; 13(1):20961. PubMed ID: 38016974 [TBL] [Abstract][Full Text] [Related]
16. Use of Human Induced Pluripotent Stem Cells and Kidney Organoids To Develop a Cysteamine/mTOR Inhibition Combination Therapy for Cystinosis. Hollywood JA; Przepiorski A; D'Souza RF; Sreebhavan S; Wolvetang EJ; Harrison PT; Davidson AJ; Holm TM J Am Soc Nephrol; 2020 May; 31(5):962-982. PubMed ID: 32198276 [TBL] [Abstract][Full Text] [Related]
17. Gene transfer may be preventive but not curative for a lysosomal transport disorder. Hippert C; Dubois G; Morin C; Disson O; Ibanes S; Jacquet C; Schwendener R; Antignac C; Kremer EJ; Kalatzis V Mol Ther; 2008 Aug; 16(8):1372-81. PubMed ID: 18578013 [TBL] [Abstract][Full Text] [Related]
18. Neurologic involvement in cystinosis: Focus on brain lesions and new evidence of four-repeat (4R-) Tau immunoreactivity. Nicoletti T; Bink A; Helmchen B; Briel N; Frontzek K; Vlad B; Gaspert A; Boudriot E; Jung HH; Reuss AM; Weller M; Hortobágyi T J Neurol Sci; 2024 Jan; 456():122841. PubMed ID: 38101161 [TBL] [Abstract][Full Text] [Related]
19. Hematopoietic Stem Cells Transplantation Can Normalize Thyroid Function in a Cystinosis Mouse Model. Gaide Chevronnay HP; Janssens V; Van Der Smissen P; Rocca CJ; Liao XH; Refetoff S; Pierreux CE; Cherqui S; Courtoy PJ Endocrinology; 2016 Apr; 157(4):1363-71. PubMed ID: 26812160 [TBL] [Abstract][Full Text] [Related]